WomenHypoactive sexual desire disorderGenitourinary syndrome of menopauseTransdermal testosterone therapy, dosed within premenopausal physiologic testosterone ranges, used alone or with menopausal hormone therapy for postmenopausal hypoactive sexual desire disorder, has shown short-term efficacy, with few ...
Disruption in the endocrine system: - phthalates can affect the adrenal cortex (H295R cells) and cause significant disturbance of steroid hormones synthesis - decreased in testosterone and increased in 17β-estradiol. Impairment of the reproductive system: - reduction in ovulatory follicles - oocytes ...